Medical Devices DECODED
Previous edition: 09 May 2024
Share article
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Biosense introduces CARTO 3 System Version 8
The latest version features new modules, including the CARTO ELEVATE Module and CARTOSOUND FAM Module.
Cardiac arrhythmia diagnosis and treatment specialist Biosense has launched CARTO 3 System Version 8, a 3D heart mapping system used in cardiac ablation procedures.
This latest version introduces new modules aimed at enhancing the reproducibility, efficiency and accuracy of catheter ablation procedures for treating atrial fibrillation (AFib) and other arrhythmias.
The software’s modules include the CARTO ELEVATE Module and the CARTOSOUND FAM Module.
Using the US Food and Drug Administration (FDA)-cleared AI algorithm, the CARTOSOUND FAM Module allows automatic generation of the left atrial anatomy before catheter insertion, offering time savings and high accuracy.
The module uses deep-learning technology, a subset of AI, to deliver automated 3D shell creation.
The CARTO ELEVATE Module incorporates several new features including the OPTRELL Mapping Catheter for localised unipolar signals, as well as complex signals identification for pinpointing areas of interest.
It also features pattern acquisition to automatically monitor arrhythmia burden and an enhanced CONFIDENSE Module for optimised mapping.
Biosense Webster president Jasmina Brooks said: “We are pleased to announce this new version of our CARTO 3 System, which reflects our continued focus on harnessing the latest science and technology to advance tools for electrophysiologists to treat cardiac arrhythmias.
“The CARTO 3 System has been the cornerstone of catheter ablation procedures for more than a decade, helping electrophysiologists make treatment decisions.
“This new version advances the CARTO 3 mapping and ablation experience through enhanced signal analysis, improved substrate characterization, and utilisation of ultrasound technology.”
Initially launched in 2009, the CARTO 3 System employs electromagnetic technology to create real-time, 3D maps of a patient's cardiac structures.
The Version 8 update also brings significant advancements, such as the OPTRELL Mapping Catheter with MULTIPOLAR technology for improved signal quality.
In March 2024, Biosense Webster filed a premarket approval application with the FDA for its VARIPULSE Platform, designed to treat paroxysmal atrial fibrillation.
Latest news
15th Annual Outsourcing in Clinical Trials East Coast 2024
The upcoming Outsourcing in Clinical Trials Europe 2024 conference will explore advancements in the clinical trial industry.
FDA issues warning on Getinge device amid quality concerns
Following a series of voluntary recalls, the FDA has urged healthcare providers to avoid Getinge’s intra-aortic balloon pumps over safety concerns.
4C Medical's AltaValve gains dual breakthrough designations from FDA
The device has received the designation for treating mitral regurgitation and mitral annular calcification.
UK report warns that economic instability is threatening life sciences sector
The report published by the Medicines Discovery Catapult warns that a mix of economic uncertainty and lack of facility access is pushing investors away from Britain’s healthcare SMEs.
Qiagen and FBI partner on DNA quant digital PCR assays
The collaboration aims to develop a first-of-its-kind digital PCR assay capable of detecting and quantifying minimal amounts of DNA with high accuracy.
Vivalink introduces new solution for MCT and Holter monitoring
The new technology combines RPM technologies with advanced arrhythmia detection algorithms.
iHealth's COVID-19/Flu rapid test secures FDA EUA
Intended for over-the-counter use, the 3-in-1 test is intended for detecting Covid-19 and influenzas A and B.
Biotechs must prioritise ethics to deter GenAI “bad actors”
At the London Biotechnology Show, Microsoft’s senior director of life sciences discussed the ethical use of GenAI.
Leica Microsystems adds Viventis Microscopy to portfolio
The addition of Viventis adds light sheet technology to Leica’s line of research microscopes.
In our previous edition
Medical Devices Decoded
Samsung to acquire foetal ultrasound AI software company Sonio
08 May 2024
Medical Devices Decoded
Medtronic's renal denervation system receives approval in China
07 May 2024
Medical Devices Decoded
Angle signs AstraZeneca deal to develop prostate cancer assay
06 May 2024
Newsletters in other sectors
Aerospace, Defence & Security
Medical Devices
Travel and Tourism
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer